LAMP3 and neoplasm: In three independent cohorts of OC patients without neoadjuvant chemotherapy, it was shown that tumor-infiltrating mature migDCs (LAMP3-DCs) served as a favorable prognostic marker and were key in eliciting anti-tumor CD8+ T-cell responses [83].